Acute Heart Failure clinical trials

Explore recruiting acute heart failure clinical trials.

Recruiting acute heart failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED TRIAL

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

OPTIMAL DIURETIC THERAPIES FOR ACUTE HEART FAILURE WITH VOLUME OVERLOAD

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Utility of intra-abdominal pressure and clinical ultrasound for guiding diuretic treatment in patients with acute heart failure

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

AP-01 i.v. as add-on treatment for acute heart failure NYHA ≥ III A mono-center, randomized double-blind, placebo-controlled study AP-01 Heart Failure (AHF) Study

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients Who Have Been Stabilized During Hospitalization for Acute Heart Failure

Poland, Hungary, Czechia

Phase III and phase IV (Integrated) EU CTIS Study details

Acetazolamide in combination with SGLT2i in patients with volume overload and acute heart failure

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Acute Heart Failure trials by city

Acute Heart Failure in Toronto Acute Heart Failure in Vancouver Acute Heart Failure in Montreal Acute Heart Failure in Calgary Acute Heart Failure in Edmonton Acute Heart Failure in Ottawa Acute Heart Failure in Winnipeg Acute Heart Failure in Quebec City Acute Heart Failure in Hamilton Acute Heart Failure in Kitchener Acute Heart Failure in London Acute Heart Failure in Halifax Acute Heart Failure in New York Acute Heart Failure in Los Angeles Acute Heart Failure in Chicago Acute Heart Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease